QNRX QUOIN PHARMACEUTICALS LTD Capital Structure Changes 8-K Filing 2025 - ADS Reverse Split Quoin Pharmaceuticals Ltd. will implement a 1-for-20 reverse split of its American Depositary Shares (ADSs) effective April 8, 2025, to meet Nasdaq's minimum bid price requirement of $1.00 per share. This change will not affect the underlying ordinary shares and aims to increase the market price of the ADSs.Get access to all SEC 8-K filings of the QUOIN PHARMACEUTICALS LTD